栄養性ライキスの治療のための低用量対高用量ビタミンD:体系的なレビューとメタ解析
Davinder Kaur1, Lovely Jain1, Pooja Dewan2
1Advanced Centre for Evidence Based Child Health (ACEBCH), Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India.
Indian pediatrics
|February 17, 2026
まとめ
低用量および高用量ビタミンDレジミンは,小児の栄養失調症の治療に類似した有効性を示しています. この研究では,2つのビタミンD投与戦略の間の結果または有害事象の有意な差異は認められませんでした.
科学分野:
- 小児内分泌学について
- 栄養科学とは,栄養科学である.
- クリニック・リサーチ 臨床研究
背景:
- 栄養失調症は,ビタミンD,カルシウム,またはリン酸欠乏から生じる.
- 現在のビタミンD治療のプロトコルは,低用量と高用量の比較効果が不明で,多様です.
研究 の 目的:
- 幼児の栄養失調症の治療のために,低用量 (≤300,000 IU) と高用量 (300,000-600,000 IU) のビタミンDの有効性と安全性を比較する.
主な方法:
- 関連するランダム化対照試験 (RCT) と準RCTに関する複数のデータベースと試験登録簿の体系的な検索.
- 2人の独立査読者が研究をスクリーニングし,データを抽出し,GRADEアプローチを使用してバイアスのリスクを評価しました.
主要な成果:
- 4つの研究が含まれた. 12週目には,低用量と高用量ビタミンD群の血清25(OH) D濃度,放射線学的改善 (タッシャースコア),副甲状腺ホルモン,またはアルカリリンフォスファターゼの有意な差異は観察されなかった.
- いずれの治療群でも深刻な不良臨床イベントは報告されていません.
結論:
- 低用量および高用量ビタミンDレジミンは,子供の栄養失調症の治療において,比較可能な有効性と安全性を示しています.
- この発見は,低用量のビタミンDレジミンがラキッツ治療の有効な選択肢である可能性があることを示唆しています.
関連する概念動画
01:22Connective Tissue Cell Types
4.3K
Connective tissue develops from the mesoderm of a developing embryo and consists of cells, fibers, and ground substance: a gel-like material containing large complexes of carbohydrates and proteins. Connective tissue was first identified as a separate tissue family in the 18th century, and Johannes Peter Muller coined the term connective tissue.
Fat cells (adipocytes), smooth muscle cells (myoblasts), and bone cells (osteoblasts) are some connective tissue cell types. Some immune system cells...
Fat cells (adipocytes), smooth muscle cells (myoblasts), and bone cells (osteoblasts) are some connective tissue cell types. Some immune system cells...
4.3K
01:23Role of Skin in Vitamin D Synthesis
8.2K
The skin plays a crucial role in the synthesis of vitamin D, a vital nutrient for various physiological processes in the body. Vitamin D is unique because it can be synthesized in the skin through a series of chemical reactions triggered by exposure to ultraviolet B (UVB) radiation from sunlight.
The solar UV B rays (290-315 nm) are absorbed by the skin, and 7-dehydrocholesterol (provitamin D3) photolyzes it to previtamin D3, which undergoes a rapid transformation to vitamin...
The solar UV B rays (290-315 nm) are absorbed by the skin, and 7-dehydrocholesterol (provitamin D3) photolyzes it to previtamin D3, which undergoes a rapid transformation to vitamin...
8.2K
01:25Role of Vitamins in Maintaining Bone Health
5.7K
The growth and maintenance of bone are regulated by a combination of nutritional factors, including vitamins, such as vitamin A, B12, C, D, and K.
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
5.7K
01:11Bioavailability Study Design: Single Versus Multiple Dose Studies
256
Bioavailability studies are essential for understanding how a drug is absorbed, distributed, metabolized, and excreted in the body. These studies assess the extent and rate at which the active pharmaceutical agent becomes available at the site of action. The design of bioavailability studies can involve single-dose or multiple-dose regimens, each with distinct advantages and limitations.Single-dose studies are the preferred approach due to their simplicity and reduced drug exposure for...
256
01:25Determination of Multiple Dosing Parameters: Loading and Maintenance Doses
272
A loading dose is an essential pharmacological strategy to rapidly achieve the target plasma drug concentration necessary for an immediate therapeutic effect. This approach is especially critical for drugs characterized by slow absorption or extended half-lives, where delaying therapeutic plasma levels could compromise treatment outcomes. By administering a loading dose, clinicians ensure a prompt onset of drug action, even for agents with complex pharmacokinetic profiles.Achieving steady-state...
272
01:29Drug Dosing: Infants and Children
344
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
344